Alternative and New Radiopharmaceutical Agents for Lung Cancer

BACKGROUND: FDG PET/CT imaging has an established role in lung cancer (LC) management. Whilst it is a sensitive technique, FDG PET/CT has a limited specificity in the differentiation between LC and benign conditions and is not capable of defining LC heterogeneity since FDG uptake varies between hist...

Descripción completa

Detalles Bibliográficos
Autores principales: Telo, Silvi, Calderoni, Letizia, Vichi, Sara, Zagni, Federico, Castellucci, Paolo, Fanti, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206190/
https://www.ncbi.nlm.nih.gov/pubmed/31868150
http://dx.doi.org/10.2174/1874471013666191223151402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206190/
https://www.ncbi.nlm.nih.gov/pubmed/31868150
http://dx.doi.org/10.2174/1874471013666191223151402

Ejemplares similares